NCT00438464View on ClinicalTrials.gov

Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Adenocarcinoma of the ProstateStage II Prostate Cancer
Interventions
DRUG

Finasteride

Given PO

OTHER

Placebo

Given PO

PROCEDURE

Prostatectomy

Undergo prostatectomy

OTHER

Laboratory biomarker analysis

Correlative studies

Trial Locations (8)

44195

Cleveland Clinic Foundation, Cleveland

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

75390

University of Texas Southwestern Medical Center, Dallas

77030

M D Anderson Cancer Center, Houston

78209

Audie L Murphy Veterans Affairs Hospital, San Antonio

78229

Cancer Therapy and Research Center, San Antonio

University Hospital, San Antonio

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
collaborator

M.D. Anderson Cancer Center

OTHER

lead

National Cancer Institute (NCI)

NIH

NCT00438464 - Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery | Biotech Hunter | Biotech Hunter